Low-Dose Naltrexone and Pain Relief in Gadolinium Deposition Disease: A Case Series

GDD/ToxicityChelatorsTreatment Options

May 31

Written By Bridget Belo

Download Article

Article link: https://www.painmedicine-casereports.com/current/pdf?article=NTUx&journal=36

Journal: American Society of Interventional Pain Physicians

Authors: Ilene Ruhoy, MD, PhD1 and Lorrin M. Koran, MD2

From: 1 Mt. Sinai South Nassau, Department of Neurology, One Healthy Way, Oceanside, NY; 2 Department of Psychiatry and Behavioral Sciences, OCD Clinic, Stanford University Medical Center, 401 Quarry Road, Stanford, CA Corresponding Author: Lorrin M. Koran, MD, E-mail: lkoran@stanford.edu

naltrexonepain

Bridget Belo

Commentary on the Association of Symptoms Associated With Gadolinium Exposure/Gadolinium Deposition Disease and Gadolinium-Based Contrast Agents (2022).

Symptoms Associated with Gadolinium Exposure (SAGE): A Suggested Term (2022).

Submit any resources that should be included on the site.

Explore Gadolinium 64

Physicians

Donate

This site is also accessible via contrastdie.com

Fair Use Disclaimer
This website features copyrighted material used in accordance with the principles of fair use as outlined in Section 107 of the U.S. Copyright Act. The material is provided to inform, educate, and encourage public discussion on important issues, including health, education, and science. All content is shared with the intent of advancing understanding and fostering meaningful dialogue. This use is non-commercial and aligns with fair use standards for purposes such as research, education, and commentary. If you believe any content on this site infringes on your copyright, please contact us at Contact Us and we will review your concerns promptly.